Dr. Vinay Prasad was rehired to lead the FDA's Center for Biologics Evaluation and Research after resigning under pressure from the White House and right-wing activist Laura Loomer. Prasad previously criticized President Donald Trump and praised Senator Bernie Sanders, which led to scrutiny of his appointment. He had stepped down to avoid being a distraction and spend more time with family, while also facing backlash for his stance on drug approvals. Upon returning, critics including Loomer condemned his reappointment, alleging he is a progressive saboteur.
Dr. Vinay Prasad returned to lead the FDA's Center for Biologics Evaluation and Research after resigning under pressure from the White House and right-wing activist Laura Loomer.
Prasad's resignation raised questions regarding the influence of political pressures on the FDA's appointments, with allegations surrounding his critical remarks about President Trump.
Loomer characterized Prasad as a progressive left saboteur and criticized the FDA's leniency in drug approvals, especially following his decision to halt a gene therapy shipment.
Prasad's return was met with outrage from right-wing critics, including Loomer, who pledged to intensify scrutiny of HHS and FDA officials.
Collection
[
|
...
]